How a GLP-1 compounding pharmacy works: a patient guide. - Reddit

What is compounding and why does it exist?

Drug compounding is the practice of preparing a customized medication for an individual patient. Compounding pharmacies have existed for most of pharmacy’s history — before commercial pharmaceutical manufacturing, pharmacists compounded nearly every medication from raw ingredients. Today, compounding fills specific gaps: patients who need doses not available commercially, formulations without certain allergens, or medications that are commercially unavailable due to shortage.

The regulatory framework that governs compounding pharmacies is defined primarily by Section 503A of the Federal Food, Drug, and Cosmetic Act. A 503A pharmacy is a state-licensed pharmacy that compounds prescription medications for individual patients based on a valid prescription from a licensed prescriber. Every prescription must be patient-specific — 503A pharmacies cannot manufacture bulk stock for general distribution.

Why GLP-1 medications ended up at compounding pharmacies

The branded GLP-1 medications for weight management — Wegovy (semaglutide) and Zepbound (tirzepatide) — experienced significant supply shortages as demand surged following their initial approvals. The FDA maintains an official drug shortage database and publishes shortage designations when commercial supply cannot meet patient demand.

During an active FDA-designated shortage of a commercially available drug, Section 503A of the FDCA permits licensed compounding pharmacies to prepare compounds containing the same active ingredient. The shortage designation is what creates the legal basis for compounded semaglutide and tirzepatide to exist — not a general right to compound any FDA-approved drug at will.

This is why the regulatory status of compounded GLP-1 medications is tied to the shortage: when and if the FDA removes semaglutide or tirzepatide from the shortage list, the legal basis for 503A pharmacies to compound them disappears.

How a 503A GLP-1 compounding pharmacy operates

A licensed 503A compounding pharmacy that prepares GLP-1 medications operates within a specific set of standards:

• State board licensure: The pharmacy holds an active license from the state board of pharmacy in the state where it operates. Multi-state shipping may require additional licensing in receiving states.
• USP Chapter 797 compliance: Sterile compounds like injectable semaglutide and tirzepatide must be prepared in a cleanroom environment meeting USP 797 standards for sterility testing, beyond-use dating, and environmental monitoring.
• Prescription requirement: A 503A pharmacy cannot dispense compounded GLP-1 medication without a valid, patient-specific prescription from a licensed prescriber who has established a patient-clinician relationship.
• Batch testing: Reputable pharmacies test batches for identity, potency, sterility, and absence of endotoxins. Results should be available as Certificates of Analysis (COAs). If a pharmacy cannot or will not produce COAs, that is a significant red flag.
• US-based sourcing: The active pharmaceutical ingredient (API) must be sourced from FDA-registered API suppliers. No offshore sourcing of the compounded preparation itself.

How does telehealth connect you to a GLP-1 compounding pharmacy?

In a clinician-supervised telehealth model, the pharmacy is one part of a larger care workflow. Here’s how the pieces connect:

1. Clinical intake: You complete a health history intake covering your goals, current medications, relevant medical history, and contraindications. A licensed clinician reviews this information.
2. Clinician evaluation: The clinician determines whether GLP-1 therapy is appropriate for you, selects a starting dose as directed, and issues a prescription.
3. Pharmacy fulfillment: The prescription goes to a licensed 503A compounding pharmacy, which compounds the medication and ships it directly to you. Shipping typically uses temperature-controlled packaging for injectable medications.
4. Ongoing monitoring:The clinician follows up to assess your response, manage any side effects, and adjust the protocol as clinically indicated. This is not a one-time transaction — ongoing oversight is part of what makes the model legitimate.

The clinician’s role is not cosmetic. They are the prescriber of record and are clinically responsible for the protocol. Providers who rubber-stamp prescriptions without a genuine review are not operating a legitimate clinical model — they are operating a pharmacy pipeline with a clinician-shaped hole in the middle.

What compounded GLP-1 is not

The popularity of GLP-1 medications has produced a parallel market of questionable products that misuse the language of compounding. It is worth being explicit about what compounded GLP-1 medication is not:

• Not an OTC supplement: No supplement contains prescription GLP-1 receptor agonists. Any product sold without a prescription and labeled as containing semaglutide or tirzepatide is mislabeled or fraudulent. GLP-1 peptides are degraded in the digestive tract and cannot be taken orally as supplements.
• Not available overseas: Medications compounded outside the US and imported without FDA authorization are not legal for personal use and carry significant safety risks related to sterility, purity, and accurate labeling.
• Not available without a prescription: Any online vendor offering injectable semaglutide or tirzepatide without requiring a clinician prescription is not operating within the legal compounding framework.
• Not equivalent to FDA-approved brands: Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy and Zepbound. The branded medications have undergone FDA review for safety, efficacy, and manufacturing consistency. Compounded preparations have not been reviewed or approved by the FDA.

PepScribe’s sourcing standard

At PepScribe, GLP-1 prescriptions are filled exclusively by US-based licensed 503A compounding pharmacies. No overseas sourcing. No gray-market supply chains. Compounded in the USA by licensed 503A pharmacies — no hidden overseas supply chain.

The sourcing standard is not a marketing claim. It is a specific operational choice with specific implications: it means every preparation is subject to US pharmacy board oversight, USP 797 sterility standards, and batch testing requirements. It means the supply chain is auditable.

If you are evaluating any GLP-1 telehealth provider — including PepScribe — you should ask these questions: which pharmacy compounds my medication, is that pharmacy licensed in my state, and can I see a Certificate of Analysis for my batch? The answers should be specific.

Frequently asked questions